10,000 cannabis studies under the microscope
This Thursday, January 12, 17 American researchers publish a balance sheet of studies carried out on cannabis in the USA since 1999. The 17 scientists compile the truths, the unanswered questions and explain why scientific information on cannabis is so scarce.
We don't know everything
Apart from THC and CBD, the roles of other cannabinoids are only partially understood. At present, researchers from all over the world are seeking to understand the role of the other cannabinoids. endocannabinoid system. By understanding this system, which is present in all mammals, humans could develop drugs that would alter the way it works, perhaps eliminating the need for cannabinoids derived from the plant.
Clinical studies on cannabis medication are extremely rare, so we rely, researchers and journalists alike, on subjective evidence such as testimonials, case improvements or behavioral changes. Steven Kinsey describes a lack of clinical trials and insufficient patient panels on the clinical trials that do take place.
The authors recommend future research on drug combinations. This combination of cannabis (in small quantities) and traditional medicines could combat chronic pain more effectively than each substance on its own. The researchers point out that no such studies have yet been conducted. Finally, the authors indirectly call for a reclassification of cannabis. At present, scientific teams have to deal with administrative pressures from their states and the federal government, which discourages many.
Validated medical uses
This compilation of studies has validated or invalidated the efficacy of cannabis in certain pathologies. Medical cannabis or its compounds are said to be effective against post-chemotherapy nausea and vomiting, in the treatment of chronic pain in adults, and in certain cases of multiple sclerosis.
Cannabis applications to check
Here are the major points that researchers will have to elucidate in the years to come: the links between cannabis and lung health. The links between cannabis and schizophrenia, bipolarity, social exclusion, depression and suicide. Links between cannabis and social success. If studies already exist, the democratization of weed will make it possible to research large panels of smokers. With all that American consumers are throwing at each other, we'll no doubt soon know whether cannabis is a real source of these symptoms.
Cannabis' efficacy neither verified nor refuted
Here are a few cannabis applications with mixed results: incidence of cancer, incidence of epilepsy, incidence of asthma (good or bad), incidence of Parkinson's and Alzheimer's patients.
We're still in the early days of cannabis research, but who 10 years ago was hearing about the therapeutic use of cannabis in France? This use has changed the perception of the plant in the United States. Perhaps it will do so here too.
-
Cannabis in France3 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Business4 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabis in France4 weeks ago
French Prime Minister Calls for Drug Testing in Government Ministries
-
Cannabis in Ukraine4 weeks ago
Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans
-
Business4 weeks ago
The SQDC exceeded $800 million in cannabis sales in 2025
-
Business3 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis


You must be logged in to post a comment Login